Core Laboratories (CLB) Operating Leases (2022 - 2026)
Core Laboratories filings provide 5 years of Operating Leases readings, the most recent being $41.3 million for Q1 2026.
- On a quarterly basis, Operating Leases fell 6.13% to $41.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $41.3 million, a 6.13% decrease, with the full-year FY2025 number at $42.3 million, down 2.39% from a year prior.
- Operating Leases hit $41.3 million in Q1 2026 for Core Laboratories, down from $42.3 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $44.0 million in Q1 2025 to a low of $38.3 million in Q4 2022.
- Median Operating Leases over the past 5 years was $42.3 million (2025), compared with a mean of $42.0 million.
- Biggest five-year swings in Operating Leases: rose 9.84% in 2023 and later decreased 6.13% in 2026.
- Core Laboratories' Operating Leases stood at $38.3 million in 2022, then grew by 9.84% to $42.1 million in 2023, then increased by 3.01% to $43.3 million in 2024, then decreased by 2.39% to $42.3 million in 2025, then fell by 2.42% to $41.3 million in 2026.
- The last three reported values for Operating Leases were $41.3 million (Q1 2026), $42.3 million (Q4 2025), and $41.5 million (Q3 2025) per Business Quant data.